miR-221, miR-650 and miR-4534 as diagnostic markers in prostate cancer and their relationship with lymphatic invasion Kuyaş Hekımler Öztürk et al, 2022, Turkish Journal of Biochemistry CrossRef
MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation Z. M. Akhokhov et al, 2023, Urology Herald CrossRef
The Clinical Usefulness of Prostate Cancer Biomarkers: Current and Future Directions Donovan McGrowder et al, 2022, Cancer Bioinformatics CrossRef
miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—archival samples study Kacper Pełka et al, 2021, Histochemistry and Cell Biology CrossRef
Analysis of miRNAs in the PSMA-positive fraction of plasma nano-sized extracellular vesicles in patients with prostate cancer L. M. Zabegina et al, 2022, Cancer Urology CrossRef
The role of miRNA in the pathogenesis of diseases associated with functional dysregulation of the lacrimal gland T.N. Safonova et al, 2023, Vestnik oftal'mologii CrossRef
Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer Giulia Marvaso et al, 2022, Cancer Management and Research CrossRef
Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
Christopher J McNally et al, 2020, Cancer Management and Research CrossRef
Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer Qionghua Tang et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects Won Tae Kim et al, 2019, International Neurourology Journal CrossRef